Key result
Point-of-care INR assessment using CoaguChek XS saved a mean of 47 ± 6 minutes compared to central laboratory testing in anticoagulated patients requiring urgent neurosurgery.
Why the study?
Does point-of-care INR assessment reduce time to result and accurately reflect central laboratory INR in anticoagulated patients requiring urgent neurosurgery?
Observational (n=17)
Does point-of-care INR assessment reduce time to result and accurately reflect central laboratory INR in anticoagulated patients requiring urgent neurosurgery?
Point-of-care INR testing in anticoagulated patients requiring urgent neurosurgery is accurate and significantly reduces the time to obtain coagulation status compared to central laboratory testing.
May expedite urgent neurosurgery decisions; leaves open prospective validation of accuracy and outcomes.
INTRODUCTION: With the increased use of oral anticoagulation with vitamin K antagonists, emergency physicians encounter a growing number of patients requiring a rapid reversal of anticoagulant effects in order to perform urgent surgical procedures. Initiation of these procedures can be delayed because the coagulation status has to be assessed through examination of blood samples in central laboratories (CL). This delay may lead to negative effects, especially in potentially life-threatening conditions such as intracranial haemorrhage. Point-of-care (POC) devices for assessment of international normalized ratio (POC INR) have improved the management of anticoagulation therapy in the outpatient setting. The use of these devices may also have beneficial effects in the treatment of anticoagulated patients requiring urgent neurosurgical procedures. The primary aim of this study was to analyse the potential of POC-guided assessment of INR to reduce time to potentially life-saving neurosurgery in this setting. Feasibility and accuracy as well as the gain of time through the use of this device were analysed. MATERIALS AND METHODS: The POC coagulometer CoaguChek XS(®) was used in 17 patients with a history of anticoagulant use and a condition requiring urgent anticoagulant reversal prior to neurosurgical procedures (burr-hole trepanation: n = 8, craniotomy: n = 7, laminectomy: n = 2). RESULTS: No technical difficulties occurred and rapid assessment of INR was achieved in all cases within 2 min. POC INR values correlated well with CL INR assessment with a mean INR deviation of 0.036 ± 0.12. The mean gain of time through the use of the POC INR device compared with CL assessment of INR was 47 ± 6 min (range: 37-61 min). CONCLUSION: Our initial experiences with a POC INR device in anticoagulated patients undergoing urgent neurosurgical procedures demonstrate that its use may contribute to an improved management of these patients.
No takes yet. Share an insight, caveat, or question.
Beynon et al. (2013) conducted an observational in Anticoagulated patients requiring urgent neurosurgical procedures (n=17). Point-of-care (POC) coagulometer (CoaguChek XS) vs. Central laboratory (CL) assessment of INR was evaluated on Reduction in time to potentially life-saving neurosurgery. Point-of-care INR assessment using CoaguChek XS saved a mean of 47 ± 6 minutes compared to central laboratory testing in anticoagulated patients requiring urgent neurosurgery.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: